期刊： THROMBOSIS RESEARCH, 2022; 209 ()
SARS-CoV-2 vaccines have been carefully developed and significantly alleviate the global pandemic. However, a rare but severe complication after vacci......
期刊： THROMBOSIS RESEARCH, 2022; 211 ()
Objectives: Venous thromboembolism (VTE) is a common health problem, causing considerable morbidity and mortality. The incidence of VTE is higher in p......
期刊： THROMBOSIS RESEARCH, 2022; 211 ()
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by neutralizing autoantibodies against coagulation Factor VIII. Immunomodulatory effec......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Introduction: Desmopressin (DDAVP) is a proven therapy for bleeding disorders; however, the therapeutic efficacy of different parenteral formulations ......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Background: Neutrophil extracellular traps (NETs) are formed by DNA, histones and proteolytic enzymes, and are produced by activated neutrophils throu......
期刊： THROMBOSIS RESEARCH, 2022; 214 ()
Introduction: Excessive activation of the coagulation cascades leads to life-threatening disseminated intravascular coagulation (DIC) in sepsis. Two r......
期刊： THROMBOSIS RESEARCH, 2022; 216 ()
Background: The coronavirus disease-2019 (COVID-19) is a systemic disease with severe implications on the vascular and coagulation system. A procoagul......
期刊： THROMBOSIS RESEARCH, 2022; 217 ()
Introduction: The central location, size, and instability of saddle pulmonary embolism (SPE) have raised significant concerns regarding its clinical, ......
期刊： THROMBOSIS RESEARCH, 2022; 220 ()
Background: Although the two manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE), vary considerably......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Introduction: Neutrophil extracellular traps (NETs) formation contributes to thrombosis but its role in atrial fibrillation (AF) is poorly explored. W......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Introduction: Thrombopoietin receptor agonists (TPO-RAs) are a reliable second-line immune thrombocytopenia (ITP) treatment. Despite an increase in us......
